[1] |
El-KHOURY J M,REINEKS E Z,WANG S. Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues[J]. Clin Biochem,2011,44(1):66-76.
|
[2] |
AFZAL S,BRØNDUM-JACOBSEN P,BOJESEN S E,et al. Vitamin D concentration,obesity,and risk of diabetes:a mendelian randomisation study[J]. Lancet Diabetes Endocrinol,2014,2(4):298-306.
|
[3] |
LAVIE C J,LEE J H,MILANI R V.Vitamin D and cardiovascular disease will it live up to its hype?[J]. J Am Coll Cardiol,2011,58(15):1547-1556.
|
[4] |
林祥泉,陈虹. 血清25-羟基维生素D水平与骨密度变化在肥胖患儿中的临床意义[J]. 检验医学,2018,33(8):669-673.
|
[5] |
周剑锁,张捷. 维生素D临床应用研究进展[J]. 检验医学,2013,28(6):539-543.
|
[6] |
ZERWEKH J E.Blood biomarkers of vitamin D status[J]. Am J Clin Nutr,2008,87(4):1087S-1091S.
|
[7] |
HOLICK M F,BINKLEY N C,BISCHOFF-FERRARI H A,et al. Evaluation,treatment,and prevention of vitamin D deficiency:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab,2011,96(7):1911-1930.
|
[8] |
MINEVA E M,SCHLEICHER R L,CHAUDHARY-WEBB M,et al.A candidate reference measurement procedure for quantifying serum concentrations of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 using isotope-dilution liquid chromatography-tandem mass spectrometry[J]. Anal Bioanal Chem,2015,407(19):5615-5624.
|
[9] |
Clinical and Laboratory Standards Institute. Defining,establishing,and verifying reference intervals in the clinical laboratory[S]. EP28-A3c,CLSI,2010.
|
[10] |
卫生部临床检验标准委员会. WS/T 402—2012 临床实验室检验项目参考区间的制定[S]. 北京:中华人民共和国卫生部,2012.
|
[11] |
YU S,FANG H,HAN J,et al.The high prevalence of hypovitaminosis D in China:a multicenter vitamin D status survey[J]. Medicine(Baltimore),2015,94(11):1.
|
[12] |
VOGESER M.Quantification of circulating 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry[J]. J Steroid Biochem Mol Biol,2010,121(3-5):565-573.
|